跳至主要内容
临床试验/NCT07462494
NCT07462494尚未招募不适用

To Evaluate the Efficacy and Safety of Probiotics in Alleviating Constipation in Adults Through a Randomized, Double-blind, Placebo-controlled Trial

Wecare Probiotics Co., Ltd.0 个研究点目标入组 30 人开始时间: 2026年6月10日最近更新:
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
30
主要终点
Changes in stool consistency

研究概览

简要总结

To evaluate the effects of probiotic intervention on gastrointestinal function in patients with constipation after 4 weeks of treatment, and to explore its potential effects on immune status and bone metabolism.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 18-65 years.
  • Patients with constipation, defined as fewer than three bowel movements per week and/or Bristol Stool Form Scale (BSFS) types 1-
  • Able to comply with the study protocol and complete the study procedures.
  • Participants who have voluntarily signed the informed consent form.
  • Participants (including male participants) must have no plans for pregnancy from 14 days before screening until 6 months after the end of the study and must agree to use effective contraception during this period.

排除标准

  • Individuals who have recently taken products with similar functions to the investigational product that may affect the evaluation of study outcomes.
  • Participants who plan to change their dietary habits during the study period.
  • Patients with severe allergies or immunodeficiency.
  • Women who are pregnant, breastfeeding, or planning to become pregnant.
  • Patients with severe diseases of major organs such as the cardiovascular system, lungs, liver, or kidneys, or those with severe metabolic diseases (e.g., diabetes or thyroid disorders), malignant tumors, or severe immune system diseases.
  • Individuals who have used antibiotics within the past two weeks.
  • Individuals with severe psychological or psychiatric disorders.
  • Participants who fail to take the investigational product as required or fail to attend scheduled follow-up visits, resulting in an inability to determine treatment efficacy.
  • Any other participants considered unsuitable for participation in the study by the investigator.

研究组 & 干预措施

Placebo group

Placebo Comparator

Maltodextrin powder administered orally once daily for 8 weeks.

干预措施: Placebo (Dietary Supplement)

结局指标

主要结局

Changes in stool consistency

时间窗: 4 weeks

Stool consistency will be evaluated using the Bristol Stool Form Scale (BSFS) to assess the improvement of constipation symptoms in patients receiving probiotic intervention.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验